Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,212) with videos related to
Page
of 122
Sort By:
American Heart Journal
|
December 5, 2016
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial
Rajendra H Mehta, Sean Van Diepen, James Meza, et al.
Journal of the American College of Cardiology
|
July 3, 2024
Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications
Sigrid Sandner, Björn Redfors, Kevin R An, et al.
British Journal of Pharmacology
|
November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P H Alexander, Eamonn Kelly, Alistair Mathie, et al.
Circulation
|
August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
Renato D Lopes, Celestia S Higano, Susan F Slovin, et al.
Pharmacological Reviews
|
June 10, 2026
International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors
Stephen P H Alexander, Kirstie A Bennett, Andrew J Brown, et al.
The New England Journal of Medicine
|
March 19, 2019
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D Lopes, Gretchen Heizer, Ronald Aronson, et al.
Circulation
|
May 29, 2008
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Mark Y Chan, Mauricio G Cohen, Christopher K Dyke, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 31, 2019
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery
Sean van Diepen, Rajendra H Mehta, Jeffrey D Leimberger, et al.
American Heart Journal
|
June 6, 2020
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
Renato D Lopes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros E Silva, et al.
Nature Reviews. Cardiology
|
March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Davide Capodanno, John H Alexander, M Cecilia Bahit, et al.
Page
of 122
Search research articles
Search
Showing results (1121-1130 of 1,212) with videos related to
Sort By:
Page
of 122
American Heart Journal
|
December 5, 2016
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial
Rajendra H Mehta, Sean Van Diepen, James Meza, et al.
Journal of the American College of Cardiology
|
July 3, 2024
Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications
Sigrid Sandner, Björn Redfors, Kevin R An, et al.
British Journal of Pharmacology
|
November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P H Alexander, Eamonn Kelly, Alistair Mathie, et al.
Circulation
|
August 30, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
Renato D Lopes, Celestia S Higano, Susan F Slovin, et al.
Pharmacological Reviews
|
June 10, 2026
International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors
Stephen P H Alexander, Kirstie A Bennett, Andrew J Brown, et al.
The New England Journal of Medicine
|
March 19, 2019
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Renato D Lopes, Gretchen Heizer, Ronald Aronson, et al.
Circulation
|
May 29, 2008
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Mark Y Chan, Mauricio G Cohen, Christopher K Dyke, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 31, 2019
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery
Sean van Diepen, Rajendra H Mehta, Jeffrey D Leimberger, et al.
American Heart Journal
|
June 6, 2020
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
Renato D Lopes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros E Silva, et al.
Nature Reviews. Cardiology
|
March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Davide Capodanno, John H Alexander, M Cecilia Bahit, et al.
Page
of 122